- Home
- MYGN vs APLD Comparison
MYGN vs APLD Comparison
Compare MYGN & APLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MYGN | APLD |
|---|---|---|
| Founded | 1991 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 625.5M | 9.3B |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | MYGN | APLD |
|---|---|---|
| Price | $6.63 | $31.99 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 12 |
| Target Price | $11.82 | ★ $30.58 |
| AVG Volume (30 Days) | 928.8K | ★ 27.6M |
| Earning Date | 02-23-2026 | 01-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $825,300,000.00 | $263,986,000.00 |
| Revenue This Year | $0.08 | $113.90 |
| Revenue Next Year | $5.28 | $71.28 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 0.21 | ★ 68.35 |
| 52 Week Low | $3.76 | $3.31 |
| 52 Week High | $15.47 | $40.20 |
Technical Indicators
Market Signals| Indicator | MYGN | APLD |
|---|---|---|
| Relative Strength Index (RSI) | 48.43 | 61.60 |
| Support Level | $6.09 | $23.42 |
| Resistance Level | $6.85 | $30.68 |
| Average True Range (ATR) | 0.27 | 2.22 |
| MACD | 0.02 | 0.70 |
| Stochastic Oscillator | 49.33 | 69.84 |
Price Performance
Historical ComparisonAbout MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About APLD Applied Digital Corporation
Applied Digital Corp is a designer, developer, and operator of next-generation digital infrastructure across North America. It provides digital infrastructure solutions and cloud services to industries like High-Performance Computing (HPC) and Artificial Intelligence (AI). The company operates in the following business segments: Data Center Hosting Business and HPC Hosting Business. The majority of its revenue is generated from the Data Center Hosting Business, which operates data centers to provide energized space to crypto mining customers.